Abstract
Purpose: To evaluate the prognostic factors in patients with Breslow skin melanoma of various thicknesses that affect the incidence of metastases in the signal lymph nodes (SLN).Material and methods: From November 2018 to November 2020, 324 patients with diagnosed melanoma of the skin of various localization and stages were examined and operated on. We used lymphotropic colloidal radiopharmaceutical (RPh) labeled with 99mTc. RPh with an activity of 150 MBq was administered one day before the operation intradermally around the scar of resected melanoma or peritumorally at 4 points in the case of a primary tumor. Lymphoscintigraphy was performed 1–3 hours after the RP injection on a Symbia E or Symbia E gamma camera (Siemens, Germany). Anteroposterior and lateral static polypositional scintigraphy was performed to determine the topography and mark the SLN. 324 planar studies were performed. In 259 cases, an additional study was performed SPECT (including SPECT / CT) on a Symbia T2 device (Siemens, Germany). Surgical intervention was performed the next day, taking into account the data of intraoperative radiometry using a domestic specialized hand-held gamma detector Radical (Amplituda, Russia).Results: The mean primary melanoma Breslow thickness was 2.77 ± 2.2 mm (range 0.2–13.0 mm). Localization of SLN: axillary (n = 161. 51 %), inguinal (n = 100. 31 %), cervical (n = 16. 5 %), submandibular (n = 9. 3 %), supraclavicular (n = 4. 1 %), more than one basin (n = 34. 9 %). In the group of melanomas <0.75 mm thick, no SLN metastases were found, among 0.75–1 mm melanomas, one positive lymph node with metastasis (SLN+) was found, in the largest group of melanomas of medium thickness (1–3.5 mm) — 25 (17 %). The largest percentage of metastases in SLN is determined in thick melanomas (>3.5 mm) — 17 (28 %), which is consistent with the data of foreign literature, while SLN is most often affected with a Breslow tumor thickness of more than 7 mm.In the group with negative sentinel lymph nodes (SLN–), the average tumor thickness according to Breslow was 2.6 ± 2.0 mm, in the SLN+ group — 4.0 ± 2.9 mm, the differences between the groups are statistically significant, which is confirmed by the result of one-way analysis of variance.The optimal threshold value of tumor thickness according to Breslow for the isolation of patients with a positive prognosis of metastasis in the SLN is 2.0 mm. It is characterized by the maximum levels of sensitivity (79 %) and specificity (59.1 %). An older age of patients (over 35 years old) is also associated with an increased incidence of metastases in the SLN, but this indicator is not statistically significant. Most often, SLN metastases were detected when the primary tumor was localized in the back (more often in men) and lower extremities (more often in women), while they are thicker (> 3.5 mm).Conclusion: 1. According to the ROC-analysis, the optimal threshold value of the tumor thickness according to Breslow for the isolation of patients with a positive prognosis of metastasis in the SLN is 2.0 mm. It is characterized by the maximum levels of sensitivity (79 %) and specificity (59.1 %). 2. Statistically significant prognostic factors of metastasis in SLN: localization of the primary tumor in the back (more often in men) and lower extremities (more often in women); Breslow thickness over 3.5 mm. 3. The absence of the influence of gender and age was noted, with a slight predominance of women in both groups.
Highlights
Толщина опухоли по Бреслоу, мм один положительный сторожевых лимфатических узлах (СЛУ), в самой многочисленной группе меланом средней толщины (1–3,5 мм) — 25 (17 %)
Krylov A.S. https://orcid.org/0000-0002-8476-7879 Abdulova L.Y. https://orcid.org/0000-0001-6799-1919 Bilik M.E. https://orcid.org/0000-0002-2592-685X
Summary
Оптимальным пороговым значением толщины опухоли по Бреслоу для выделения больных с положительным прогнозом метастазирования в СЛУ является 2,0 мм. По данным ROC-анализа, оптимальным пороговым значением толщины опухоли по Бреслоу для выделения больных с положительным прогнозом метастазирования в СЛУ является 2,0 мм. 2. Статистически значимые прогностические факторы метастазирования в СЛУ: локализация первичной опухоли в области спины (чаще у мужчин) и нижних конечностей (чаще у женщин); толщина по Бреслоу более 3,5 мм. Для цитирования: Николаева Е.А., Крылов А.С., Рыжков А.Д., Абдулова Л.Ю., Билик М.Е., Захарова Т.В., Барышников К.А. Хотя это исследование было небольшим, в нем участвовало всего 98 пациентов, общие результаты многократно воспроизводились в течение последующих десятилетий, в результате чего толщина меланомы по Бреслоу теперь рассматривается как определяющий фактор [9, 10] и является основой для определения стадии T в классификации TNM [11, 12]. Уточнение локализации и количества выявленных пораженных лимфатических узлов дает возможность уточнить стадию опухолевого процесса [23]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of oncology: diagnostic radiology and radiotherapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.